With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers ...

Draft guidance from reimbursement authority NICE has recommended use of the artificial intelligence technologies – Aidoc ...

The plan – backed with a £2 billion ($2.68 billion) funding pledge – revolves around three overarching objectives, namely ...

At ASCO 2025, Johnson & Johnson contributed more than 70 abstracts, reflecting the depth of their oncology portfolio, and commitment to redefining what’s possible for a wide range of solid tumour and ...

From dissecting clinical updates to identifying novel targets beyond NLRP3, this summit brings together the brightest minds transforming the field of innate immunity and inflammation.

Developing new biomarker assays is highly specialised work. It requires careful screening of antibody pairs, sensitivity and specificity testing, and performance validation across different sample ...

Just over two years into Anderson's tenure, Bayer's board has decided to extend his contract by three years to 31st March, 2029, with company chairman Norbert Winkeljohann saying: "We're starting to ...

Healthinote is a smartphone-based toolkit designed to boost patient engagement by providing personalised, trustworthy, and ...

An antibody being developed by AstraZeneca for the treatment of light chain (AL) amyloidosis has failed to move the needle in ...

The UK Biobank has completed the world's largest whole body imaging project, compiling more than a billion scans from 100,000 ...

The readout is particularly welcome for AZ as baxdrostat (formerly CIN-107) showed mixed results in earlier hypertension ...

A series of adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting ...